News
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Merck announced plans to ... according to filings with the New Jersey Department of Labor. The company has over 3,000 employees working at its campus in East Hanover, and 12,000 employees ...
The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, which included BMS and Novartis cuts.
Hosted on MSN17d
Merck opens $1 billion addition in north Durham to boost production of popular vaccineThe drugmaker Merck announced it has opened a $1 billion ... among other illnesses. Six years ago, the New Jersey company signed incentive deals with North Carolina and local governments to ...
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.Led by researchers ...
1d
News-Medical.Net on MSNBlood test for tumor DNA may predict melanoma recurrenceMonitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Story April 10 - Pfizer: The Big Pharma sold its five-building campus, located on Science ... The women’s health drugmaker is initiating New Jersey layoffs that will hit 93 staffers.
Novartis is also cutting 34 jobs at its Campus Point manufacturing ... With operations in Rockville, MD, and Short Hills, NJ, I-Mab had approximately 220 employees as of December 31, 2023. Johnson & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results